Publication | Closed Access
Correlation of the mutation of p53 gene and the polymorphism at codon 72 in smoking-related non-small cell lung cancer patients.
38
Citations
0
References
1998
Year
GeneticsGenetic EpidemiologyHuman PolymorphismPathologyTobacco ControlCodon 72Public HealthMolecular DiagnosticsSmoking Related Lung DiseaseMolecular OncologyCancer ResearchMedicineMutation RateCancer GeneticsLung CancerP53 PolymorphismBronchial NeoplasmNsclc PatientsOncologyP53 Gene
The polymorphism of p53 gene at codon 72 consisting of either arginine (Arg)- or proline (Pro)-encoded allele is suggested to be associated with the susceptibility of tobacco-related lung cancer. In this study we examined the polymorphism of 224 non-small cell lung cancer (NSCLC) patients and that of 303 control persons with a polymerase chain reaction method and found that Pro-allele carriers were significantly more frequent in those patients who smoked and were affected at a younger age (<65) (P<0.05). We also investigated whether the mutational alterations of this gene could be influenced by the genotype. The overall mutation rate of 114 NSCLC patients examined with a single-strand conformation polymorphism method was 31%, which agreed with previous reports. However, the mutation rate was significantly increased in those patients who smoked and were affected at a younger age (<65) (P<0.05). Although the Pro-allele carriers among the smoker patients showed higher mutation rate than the Arg/Arg homozygotes, the difference between the genotypes had marginal significance (0.1<P<0.05) and was statistically insignificant, if the study was confined to younger patients. Thus, the present data cannot confirm a possible association of the p53 polymorphism with its mutation rate regarding smoking-related lung cancer.